Lcnb Corp Merck & Co., Inc. Transaction History

Lcnb Corp

$267 Million
Q2 2024

A detailed history of Lcnb Corp transactions in Merck & Co., Inc. stock. As of the latest transaction made, Lcnb Corp holds 19,963 shares of MRK stock, worth $2.04 Million. This represents 0.93% of its overall portfolio holdings.

Number of Shares

19,963

Previous 20,015 0.26%

Holding current value

$2.04 Million

Previous $2.64 Million 6.4%

% of portfolio

0.93%

Previous 0.96%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$123.8 - $132.96 $6,437 - $6,913	-52 Reduced 0.26%	19,963 $2.47 Million
Q1 2024 May 10, 2024	SELL	$113.24 - $131.95 $44,163 - $51,460	-390 Reduced 1.91%	20,015 $2.64 Million
Q4 2023 Feb 12, 2024	SELL	$100.18 - $109.02 $100 - $109	-1 Reduced -0.0%	20,405 $2.22 Million
Q3 2023 Nov 13, 2023	SELL	$102.95 - $114.33 $16,163 - $17,949	-157 Reduced 0.76%	20,406 $2.1 Million
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $32,583 - $35,514	-300 Reduced 1.44%	20,563 $2.37 Million
Q1 2023 May 03, 2023	SELL	$102.94 - $114.86 $141,027 - $157,358	-1,370 Reduced 6.16%	20,863 $2.22 Million
Q4 2022 Feb 10, 2023	SELL	$87.44 - $112.11 $44,769 - $57,400	-512 Reduced 2.25%	22,233 $2.47 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $52,915 - $59,444	626 Added 2.83%	22,745 $1.96 Million
Q2 2022 Aug 12, 2022	BUY	$83.49 - $94.64 $62,617 - $70,980	750 Added 3.51%	22,119 $2.02 Million
Q1 2022 May 13, 2022	SELL	$73.51 - $82.4 $10,291 - $11,536	-140 Reduced 0.65%	21,369 $1.75 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $661,362 - $828,441	9,150 Added 74.04%	21,509 $1.65 Million
Q3 2021 Nov 12, 2021	BUY	$71.68 - $78.83 $70,963 - $78,041	990 Added 8.71%	12,359 $928,000
Q2 2021 Aug 13, 2021	BUY	$70.31 - $77.77 $105,465 - $116,655	1,500 Added 15.2%	11,369 $884,000
Q1 2021 May 13, 2021	SELL	$68.86 - $81.11 $28,301 - $33,336	-411 Reduced 4.0%	9,869 $761,000
Q3 2020 Nov 12, 2020	SELL	$73.18 - $82.95 $21,954 - $24,885	-300 Reduced 2.84%	10,280 $853,000
Q2 2020 Aug 12, 2020	SELL	$70.42 - $80.13 $23,942 - $27,244	-340 Reduced 3.11%	10,580 $818,000
Q1 2020 May 11, 2020	BUY	$63.36 - $87.82 $38,016 - $52,691	600 Added 5.81%	10,920 $840,000
Q4 2019 Feb 10, 2020	SELL	$77.58 - $87.54 $15,516 - $17,508	-200 Reduced 1.9%	10,320 $938,000
Q3 2019 Nov 08, 2019	BUY	$76.08 - $82.93 $66,417 - $72,397	873 Added 9.05%	10,520 $886,000
Q2 2019 Aug 01, 2019	SELL	$69.84 - $81.59 $3,561 - $4,161	-51 Reduced 0.53%	9,647 $809,000
Q4 2018 Feb 19, 2019	SELL	$65.24 - $75.71 $3,261 - $3,785	-50 Reduced 0.51%	9,698 $741,000
Q3 2018 Nov 09, 2018	SELL	$57.69 - $67.84 $17,307 - $20,352	-300 Reduced 2.99%	9,748 $692,000
Q2 2018 Aug 13, 2018	BUY	$50.83 - $59.72 $1,270 - $1,493	25 Added 0.25%	10,048 $610,000
Q1 2018 May 15, 2018	SELL	$50.96 - $59.23 $8,408 - $9,772	-165 Reduced 1.62%	10,023 $546,000
Q4 2017 Feb 13, 2018	BUY	$51.62 - $61.64 $9,652 - $11,526	187 Added 1.87%	10,188 $574,000
Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $19,067 - $20,517	325 Added 3.36%	10,001 $641,000
Q2 2017 Aug 14, 2017	BUY	N/A	9,676	9,676 $620,000

Others Institutions Holding MRK

# of Institutions

3,807

Shares Held

1.92B

Call Options Held

13.4M

Put Options Held

10.6M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $259B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lcnb Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lcnb Corp with notifications on news.

Account